Abstract:Sulforaphane (SFN), an isothiocyanate, is one of the major dietary phytochemicals found in cruciferous vegetables. Many studies suggest that SFN can protect against cancer and cardiometabolic diseases. Despite the proposed systemic and local vascular protective mechanisms, SFN's potential to inhibit atherogenesis by targeting macrophages remains unknown. In this study, in high fat diet fed ApoE-deficient (ApoE−/−) mice, oral SFN treatment improved dyslipidemia and inhibited atherosclerotic plaque formation and the unstable phenotype, as demonstrated by reductions in the lesion areas in both the aortic sinus and whole aorta, percentages of necrotic cores, vascular macrophage infiltration and reactive oxygen species (ROS) generation. In THP-1-derived macrophages, preadministration SFN alleviated oxidized low-density lipoprotein (ox-LDL)-induced lipid accumulation, oxidative stress and mitochondrial injury. Moreover, a functional study revealed that peritoneal macrophages isolated from SFN-treated mice exhibited attenuated cholesterol influx and enhanced apolipoprotein A-I (apoA-I)- and high-density lipoprotein (HDL)-mediated cholesterol efflux. Mechanistic analysis revealed that SFN supplementation induced both intralesional and intraperitoneal macrophage phenotypic switching toward high expression of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1) and ATP-binding cassette subfamily A/G member 1 (ABCA1/G1) and low expression of peroxisome proliferator-activated receptor γ (PPARγ) and cluster of differentiation 36 (CD36), which was further validated by the aortic protein expression. These results suggest that the regulation of macrophages' cholesterol transport and accumulation may be mainly responsible for SFN's potential atheroprotective properties, and the regulatory mechanisms might involve upregulating ABCA1/G1 and downregulating CD36 via the modulation of PPARγ and Nrf2.

Essential role of Nrf2 in sulforaphane-induced protection against angiotensin II-induced aortic injury

Sulforaphane inhibits angiotensin II-induced cardiomyocyte apoptosis by acetylation modification of Nrf2

Sulforaphane Protects Against Cardiovascular Disease Via Nrf2 Activation.

Sulforaphane Prevention of Diabetes-Induced Aortic Damage Was Associated with the Up-Regulation of Nrf2 and Its Down-Stream Antioxidants

Sulforaphane Attenuation of Type 2 Diabetes-Induced Aortic Damage Was Associated with the Upregulation of Nrf2 Expression and Function

Sulforaphane attenuates angiotensin II-induced human umbilical vein endothelial cell injury by modulating ROS-mediated mitochondrial signaling

Sulforaphane Attenuates Angiotensin Ii-Induced Vascular Smooth Muscle Cell Migration Via Suppression Of Nox4/Ros/Nrf2 Signaling

Nrf2 Deficiency Aggravates Angiotensin II-induced Cardiac Injury by Increasing Hypertrophy and Enhancing IL-6/STAT3-dependent Inflammation.

Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through suppression of p38 and JNKsignaling

Protective Effect of Sulforaphane on Human Vascular Endothelial Cells Against Lipopolysaccharide-Induced Inflammatory Damage

Nrf2 Expression and Function, but Not MT Expression, is Indispensable for Sulforaphane-Mediated Protection Against Intermittent Hypoxia-Induced Cardiomyopathy in Mice.

Up-regulation of P27kip1 Contributes to Nrf2-mediated Protection Against Angiotensin II-induced Cardiac Hypertrophy

Sulforaphane protects microvascular endothelial cells in lower limb ischemia/reperfusion injury mice

Sulforaphane Prevents Angiotensin II-Induced Testicular Cell Death Via Activation of NRF2

Sulforaphane alleviates lung ischemia‑reperfusion injury through activating Nrf‑2/HO‑1 signaling

Metallothionein Is Downstream Of Nrf2 And Partially Mediates Sulforaphane Prevention Of Diabetic Cardiomyopathy

FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells Via Activating the AMPK-SIRT1 Signal Pathway

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

Sulforaphane Attenuates Acute Lung Injury by Inhibiting Oxidative Stress Via Nrf2/HO-1 Pathway in a Rat Sepsis Model.

Sulforaphane Inhibits Foam Cell Formation and Atherosclerosis via Mechanisms Involving the Modulation of Macrophage Cholesterol Transport and the Related Phenotype

Nrf2 at the heart of oxidative stress and cardiac protection